Concepedia

Pieter J.A. Eichhorn

PJ

20

Publications

3.3K

Citations

18

H-Index

2004

Active since

Affiliations

National University of Singapore(Current)

National University Cancer Institute, Singapore

Vall d'Hebron Institute of Oncology

Massachusetts General Hospital

The Netherlands Cancer Institute

Pieter J.A. Eichhorn is an author at National University of Singapore specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2004–2020

20

Publications

20

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

Violeta Serra, Ben Markman, Maurizio Scaltriti et al. · Cancer Research · 2008 · 795 citations · Full text

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Violeta Serra, Maurizio Scaltriti, Ludmila Prudkin et al. · Oncogene · 2011 · 530 citations · Full text

Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235

Pieter J.A. Eichhorn, Magüi Gili, Maurizio Scaltriti et al. · Cancer Research · 2008 · 483 citations · Full text

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

Pieter J.A. Eichhorn, Laura Rodón, Alba Gonzàlez-Juncà et al. · Nature Medicine · 2012 · 396 citations

, , +6

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2 <sup>+</sup> breast cancer patients

Maurizio Scaltriti, Pieter J.A. Eichhorn, Javier Cortés et al. · Proceedings of the National Academy of Sciences · 2011 · 320 citations

Rows per page

1–5 of 20